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Cardiolipin (CL) is a unique, dimeric phospholipid essential for mitochondrial
dynamics in eukaryotic cells. Dynamin-related protein 1 (Drp1), a member of
the dynamin superfamily of large GTPases, maintains the balance of mitochon-
drial division and fusion by rapidly catalyzing mitochondrial fission. Although
recent studies have indicated a role for CL in stimulating Drp1 self-assembly as
well as GTPase activity on the mitochondrial surface, the exact mechanism by
which CL functions in membrane fission remains unclear. Here we use a variety
of fluorescence spectroscopic and imaging approaches, together with model
membranes, to demonstrate that Drp1 and CL function cooperatively in effect-
ing membrane fission in three distinct steps: (i) Drp1’s preferential association
with unconstrained, fluid-phase CL molecules located at a high spatial density
in the membrane bilayer, (ii) CL’s reorganization in concert with Drp1 self-
assembly, and (iii) CL’s rapid phase transition from a lamellar, bilayer structure
to an inverted hexagonal, non-bilayer configuration in the presence of Drp1 and
GTP, resulting in the creation of localized membrane constrictions that are
primed for fission. We propose that Drp1 thus catalyzes mitochondrial division.
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The Voltage Dependent Anion Channel (VDAC) forms the major pathway for
metabolites across the mitochondrial outer membrane (MOM). Mammalian
mitochondria have three isoforms of this protein: VDAC1, VDAC2, and
VDAC3 which may play different roles in the regulation of mitochondrial func-
tions. VDAC1 is the most studied isoform, since it is the major protein of the
MOM in most cells, followed by VDAC2. Both, VDAC1 and VDAC2 recon-
stituted into planar membranes form voltage-dependent anion-selective chan-
nels whose conductance is modulated by dimeric tubulin. As counterpart, the
poor channel-forming ability of VDAC3 together with its low proficiency in
restoring normal growth in pore-less yeast led to hypothesize that this isoform
does not form channels and could be just a modulator of the other two isoforms.
We developed an improved protocol of purification and refolding of mouse re-
combinant VDAC3 that allowed us to fully characterize channels formed by
VDAC3 reconstituted in planar lipid membranes and to compare its channel
properties with those of VDAC1 and VDAC2. We observed the typical
VDAC channel behavior of VDAC3, such as high conductive open state
(3.5-4.1 nS in 1M KCl) and multiple low conductive states at potentials R
540mV, selectivity for anions with PCl
-/PK
þ¼ 1.7, and typical voltage-
gating. This suggests a structural homology of VDAC3 with the other two iso-
forms. Interestingly, the most distinct characteristic of VDAC3 is its signifi-
cantly lower sensitivity to the blockage by tubulin, which would lead to an
increased permeability of this channel to ATP and other metabolites. This
might explain why the down-regulation of VDAC3 expression among the three
VDAC isoforms in some cancer cells causes the most drastic decrease in their
mitochondrial membrane potential, or why VDAC3 is predominantly ex-
pressed in the short-term high energy demanding cells, such as spermatozoa.
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Mitochondria are the main source of energy in eukaryotic non-proliferating aer-
obic cells. In cancer cells, significant part of the energy metabolism is sup-
ported by the aerobic glycolysis. Oxidative phosphorylation metabolites
cross the mitochondrial outer membrane through the voltage dependent anion
channel (VDAC). The possibility of the voltage-gating functioning of VDAC
under physiological conditions and proposed mechanisms of generation of
the outer membrane potential (OMP) require further study. In this work, we
present a computational thermodynamic analysis of a possible generation of
OMP by the creatine kinase(CK)-VDAC and VDAC-hexokinase(HK) com-
plexes, as well as by their intermembrane complexes with the adenine nucleo-
tide translocator (ANT). The CK-VDAC and VDAC-HK complexes function
as direct steady-state voltage generators, using the free energy of kinase reac-tions, while the ANT-CK-VDAC and ANT-VDAC-HK complexes allow the
application of a part of the sum of the corresponding ‘‘kinase voltage’’ and
the inner membrane potential to the outer membrane. The developed computa-
tional models demonstrate a high probability of generation of the
metabolically-dependent OMP with magnitudes high enough to close free
VDACs. We suggest that in case of cardiac cells, the CK-VDAC-mediated
channeling of mitochondrial energy, earlier postulated by Saks and Wallimann,
leads to the metabolically-dependent generation of a high OMP during systole,
thus causing electrical closure of free VDACs and essentially avoiding the
mitochondrial ATP usage by non-contraction system consumers. In case of
cancer cells, that have a very high percentage of hexokinase attached to mito-
chondria, the electrical closure of free VDACs by OMP allows the preferential
VDAC-HK-mediated channeling of the mitochondrial ATP to initiate the aer-
obic glycolysis by an anti-turbo mode. (Research grants #111852128625 and
#520154531565, Colciencias).
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Alpha-synuclein (a-syn), an intrinsically disordered neuronal protein, is impli-
cated in the etiology of Parkinson disease (PD) and a number of other neurode-
generative dementias. Though recent research demonstrates the involvement of
a-syn in a variety of mitochondrial dysfunction in neurodegeneration, the mo-
lecular mechanism of a-syn toxicity and its effect on neuronal mitochondria
remain vague. We demonstrate a functional interaction between a-syn and
the voltage-dependent anion channel (VDAC), the major conduit for ATP
and other bioenergetics metabolites in the mitochondrial outer membrane.
We found that at nanomolar concentrations, the full-length a-syn, its 45 amino
acid C-terminal truncated mutant, as well as b- and a-synuclein isoforms
induce reversible and highly voltage-dependent blockage of VDAC reconsti-
tuted into planar lipid bilayers. Binding parameters varied with each isoform,
revealing the key role of the negatively charged C-terminal of synucleins in
blocking a positively charged pore of VDAC. Synuclein-blocked states of
VDAC differ in ionic selectivity, implying the existence of several conforma-
tion states of synuclein molecules in the channel pore. We propose a model of
a-syn interaction with VDAC, in which the negatively charged C-terminus of
a-syn enters the net-positive channel pore, providing a steric block for ATP
flux. Experiments with a yeast strain deficient in VDAC1 demonstrate that
a-syn toxicity in yeast depends on VDAC, revealing a-syn interaction with
the channel in living cells. Thus, our findings show the long-sought physiolog-
ical and pathophysiological roles for monomeric a-syn, which reconcile previ-
ous observations of various synuclein effects on mitochondrial bioenergetics.
3065-Pos Board B495
Mitochondrial DNA: The Heart of the Matter
Meagan McManus1, Martin Picard1, Alessia Angelin1, Prasanth Potluri1,
Jagat Narula2, Douglas Wallace1.
1CHOP/UPENN, Philadelphia,, PA, USA, 2Mt Sinai, New York, NY, USA.
Cardiac conduction defects and cardiomyopathy are commonly reported in pa-
tients with inborn errors of metabolism harboring pathogenic mutations in
either mitochondrial or nuclear DNA (mtDNA and nDNA, respectively). We
hypothesized that the pathophysiology of inborn errors of metabolism varies
due to synergistic heterozygosity between the two genomes. We examined a
13-generation Mennonite pedigree with autosomal recessive cardiomyopathy
due a mutation in the adenine nucleotide translocator-1 (ANT1). Substantial
variability in the progression of heart disease segregated with maternal lineage,
and the severity of cardiomyopathy correlated with the mtDNA haplogroups
(Strauss, et al 2013). To determine the causative nature of this correlation,
we examined the influence of inherited mtDNA mutations on ANT1-
cardiomyopathy in the mouse. We introduced homoplasmic mtDNA ND6 or
COI missense mutations into the mouse female germ line, generating mice
with complex I or IV deficiency, respectively, and analyzed Ant1-dependent
cardiomyopathy on the different mtDNA backgrounds. On wt mtDNA back-
ground, the Ant1-/- mice developed a distinctive concentric dilated cardiomy-
opathy, characterized by substantial myocardial hypertrophy and ventricular
dilation. Both COI and ND6 mtDNA mutations accelerated Ant1-/- age-
dependent cardiomyopathy, as evidenced by ultrastructrural abnormalities, bio-
energetic defects, mtROS production, sensitized mitochondrial permeability
transition, increased mtDNA damage, and heart failure, which ultimately
